Caliper Life Sciences, Inc. - Financial and Strategic SWOT Analysis
Review
Reference Code: GDPH5572FSA Publication Date: AUG 2012
68 Elm Street Phone +1 508 4359500 Revenue NA
Hopkinton, MA Fax +1 508 4353439 Net Profit 4.28 (million USD)
01748 Website www.caliperls.com Employees 469
Pharmaceuticals &
United States Exchange Industry
Healthcare
Company Overview
Caliper Life Sciences, Inc. (Caliper) is a provider of integrated systems including instruments, software, and reagents to life
sciences biomedical and pharmaceutical researchers all over the world. The company’s portfolio of offerings include state-of-the-
art microfluidic systems, lab automation and liquid handling systems, optical imaging technologies, and discovery and
development outsourcing solutions. It provides cutting-edge technologies to researchers in the life sciences industry enabling
them to create life-saving and enhancing medicines and diagnostic tests. Caliper is headquartered in Hopkinton, Massachusetts,
the US.
Key Executives SWOT Analysis
Name Title Caliper Life Sciences, Inc., SWOT Analysis
E. Kevin Hrusovsky President, Life Sciences Strengths Weaknesses
and Technology
Source: Annual Report, Company Website, Primary and Secondary
Highly Enabling Technologies Reliance on Third Party
Research, GlobalData
Diversified Products and
Share Data Services Portfolio
Caliper Life Sciences, Inc.
Share Price (USD) as on 04-Nov- 10.49 Opportunities Threats
2011
Strategic Agreements Competitive Pressures
EPS (USD) 0.08
Market Cap (million USD) 579 New Product Launches Cost Containment Pressures
Enterprise Value (million USD) 543
Shares Outstanding (million) 55 Source: Annual Report, Company Website, Primary and Secondary Research,
GlobalData
Source: Annual Report, Company Website, Primary and Secondary
Research, GlobalData
Financial Performance Recent Developments
Nov 03, 2011 Caliper Reports Revenues Of $36.9m In Q3
2011
Aug 08, 2011 Caliper And Carestream Settle Lawsuits
Aug 02, 2011 Caliper Reports Total Revenues Of $38.3m In
Q2 2011
Jun 06, 2011 Caliper To Present Key Findings On
Applications Of Multispectral Imaging And
Pattern Recognition Technology At ASCO
2011 Annual Meeting
Source: Annual Report, Company Website, Primary and Secondary Source: Annual Report, Company Website, Primary and Secondary Research,
Research, GlobalData GlobalData
Caliper Life Sciences, Inc. - Financial and Strategic SWOT Reference Code: GDPH5572FSA
Analysis Review
Source : www.globalcompanyintelligence.com Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Table of Contents
Table of Contents ............................................................................................................................................................................... 2
List of Tables .................................................................................................................................................................................. 3
List of Figures ................................................................................................................................................................................. 4
Section 1 - About the Company.......................................................................................................................................................... 5
Caliper Life Sciences, Inc. - Key Facts ............................................................................................................................................... 5
Caliper Life Sciences, Inc. - Key Employees ...................................................................................................................................... 6
Caliper Life Sciences, Inc. - Major Products and Services ................................................................................................................. 7
Caliper Life Sciences, Inc. - History.................................................................................................................................................... 9
Caliper Life Sciences, Inc. - Company Statement ............................................................................................................................ 12
Caliper Life Sciences, Inc. - Locations And Subsidiaries .................................................................................................................. 13
Head Office ................................................................................................................................................................................... 13
Other Locations & Subsidiaries ..................................................................................................................................................... 13
Section 2 – Company Analysis ......................................................................................................................................................... 15
Caliper Life Sciences, Inc. - Business Description ........................................................................................................................... 15
Caliper Life Sciences, Inc. - SWOT Analysis .................................................................................................................................... 16
SWOT Analysis - Overview........................................................................................................................................................... 16
Caliper Life Sciences, Inc. - Strengths .......................................................................................................................................... 16
Strength - Highly Enabling Technologies .................................................................................................................................. 16
Strength - Diversified Products and Services Portfolio .............................................................................................................. 16
Caliper Life Sciences, Inc. - Weaknesses ..................................................................................................................................... 16
Weakness - Reliance on Third Party ......................................................................................................................................... 16
Caliper Life Sciences, Inc. - Opportunities .................................................................................................................................... 17
Opportunity - Strategic Agreements .......................................................................................................................................... 17
Opportunity - New Product Launches........................................................................................................................................ 17
Opportunity - Emerging Markets ............................................................................................................................................... 17
Caliper Life Sciences, Inc. - Threats ............................................................................................................................................. 17
Threat - Competitive Pressures ................................................................................................................................................. 17
Threat - Cost Containment Pressures ....................................................................................................................................... 17
Threat - Rapid Technological Change ....................................................................................................................................... 18
Caliper Life Sciences, Inc. - Key Competitors .................................................................................................................................. 19
Section 3 – Company Financial Ratios ............................................................................................................................................. 20
Financial Ratios - Capital Market Ratios........................................................................................................................................... 20
Financial Ratios - Annual Ratios ...................................................................................................................................................... 20
Performance Chart ........................................................................................................................................................................... 22
Financial Performance...................................................................................................................................................................... 22
Financial Ratios - Interim Ratios....................................................................................................................................................... 23
Financial Ratios - Ratio Charts ......................................................................................................................................................... 24
Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 25
Caliper Life Sciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012................................................... 25
Caliper Life Sciences, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012 .................................................. 26
Caliper Life Sciences, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012 .................................................................... 27
Caliper Life Sciences, Inc., Medical Equipment, Deals By Type, 2006 to YTD 2012 .................................................................... 28
Caliper Life Sciences, Inc., Recent Deals Summary ........................................................................................................................ 29
Section 5 – Company’s Recent Developments ................................................................................................................................ 30
Caliper Life Sciences, Inc., Recent Developments ....................................................................................................................... 30
Caliper Life Sciences, Inc. - Financial and Strategic SWOT Reference Code: GDPH5572FSA
Analysis Review
Source : www.globalcompanyintelligence.com Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Nov 03, 2011: Caliper Reports Revenues Of $36.9m In Q3 2011............................................................................................. 30
Aug 08, 2011: Caliper And Carestream Settle Lawsuits............................................................................................................ 30
Aug 02, 2011: Caliper Reports Total Revenues Of $38.3m In Q2 2011 .................................................................................... 31
Jun 06, 2011: Caliper To Present Key Findings On Applications Of Multispectral Imaging And Pattern Recognition Technology
At ASCO 2011 Annual Meeting ................................................................................................................................................. 32
May 02, 2011: Caliper Reports Total Revenues Of $35.8m In Q1 2011 ................................................................................... 32
Apr 05, 2